Lipidemia Clinical Trials in Beijing, Beijing Municipality
7 recruitingBeijing, Beijing Municipality, China
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.760 enrolled2 locationsNCT07421297
Recruiting
Not Applicable
Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
PrehypertensionBorderline Dyslipidemia
Beijing Anzhen Hospital1,400 enrolled3 locationsNCT07372729
Recruiting
Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography
Diabetes MellitusHypertensionDyslipidemias
Beijing Tongren Hospital300 enrolled1 locationNCT05644548
Recruiting
Phase 3
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
DyslipidemiasHypercholesterolemia
Hasten Biopharmaceutical Co., Ltd.210 enrolled18 locationsNCT06568471
Recruiting
Not Applicable
Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients with Hyperlipidemia
Hyperlipidemias
Peking Union Medical College Hospital120 enrolled1 locationNCT05015348
Recruiting
Phase 3
Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
Primary Hypercholesterolaemia and Mixed Dyslipidemia
Shanghai Junshi Bioscience Co., Ltd.582 enrolled1 locationNCT05621070
Recruiting
Integrated Diagnosis and Treatment of CKD on Outcomes
HypertensionChronic Kidney DiseasesHyperlipidemias+4 more
Capital Medical University1,000 enrolled1 locationNCT05242055